Drug Description in Trials / DrugBank / KEGG DRUG /

  

Search results

No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1(-)-Epicatechin[1] Epicatechin---[2] 86, 113 💬
2(18F)FPGLU----[1] 86 💬
3(Pyr1)apelin-13----[1] 86 💬
4(S)-2-(4,6-dimethylpyrimidin-2-yloxy)-3-methoxy-3,3-diphenylpropanoic acid----[1] 86 💬
5(S)-3-((3-(1-((6-(3,4-DIMETHOXYPHENYL)PRYAZIN-2- YL)AMINO)ETHYL)PHENYL)CARBAMOYL)-5-METHYLPRIDIN-1-IUM----[1] 86 💬
6(S)-3-((3-(1-((6-(3,4-DIMETHOXYPHENYL)PRYAZIN-2-YL)AMINO)ETHYL)PHENYL)CARBAMOYL)-5-METHYLPRIDIN-1-IUM----[1] 86 💬
7**Comment**- IMP inhalation solution identical to ventavis inhalation solution, but IMP is in a different volume presentation. Please see covering letter.[1] Iloprost[1] Iloprost 💬[1] PTGIR 💬[3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬[1] 86 💬
810-nitro-9(E)-octadec-9-enoic acid----[1] 86 💬
911C-ACETATE[2] Acetate,
Acetic acid C-11		---[4] 6, 13, 86, 88 💬
10120 mg sodium nitrite inhalation solution[1] Nitrite---[1] 86 💬
11129Xe Hyperpolarized----[1] 86 💬
1215 mg sodium nitrite inhalation solution[1] Nitrite---[1] 86 💬
13150mg CXA-10[1] CXA-10---[1] 86 💬
14171----[1] 86 💬
152-(4-[5,6-diphenylpyrazin-2-yl)(isopropyl)amino]butoxy)-N-(methylsulfonyl)actamide----[1] 86 💬
162-{4-[(5,6-diphenylpyrazin-2-yl)(isopropyl)amino]butoxy}-N-(methylsulfonyl) acetamide[1] Acetamide---[1] 86 💬
1720 mg sildenafil citrate by mouth[1] Sildenafil[1] Sildenafil 💬[1] PDE5A 💬[3] Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬[1] 86 💬
1820 mg/ml Treprostinil[1] Treprostinil[1] Treprostinil 💬[1] PTGIR 💬[3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬[1] 86 💬
1925% MTD sodium nitrite inhalation solution[1] Nitrite---[1] 86 💬
20400 mg BIA 5-1058[1] BIA---[1] 86 💬
2145 mg sodium nitrite inhalation solution[1] Nitrite---[1] 86 💬
224AU76----[1] 86 💬
2366215-101----[1] 86 💬
246R-BH4[1] Sapropterin[1] Sapropterin 💬--[3] 86, 124, 240 💬
2575mg CXA-10[1] CXA-10---[1] 86 💬
2690 mg sodium nitrite inhalation solution[1] Nitrite---[1] 86 💬
27: 2-{4-[(5,6-difenilpirazin-2-yl)(isopropil)amino]butoxi}-N-----[1] 86 💬
28[11C]-GSK2256098 500 MBq[1] GSK2256098---[1] 86 💬
29[18F] FES----[1] 86 💬
30[18F]Fluoro-2-deoxy-2-D-glucose[2] D-glucose,
Dextrose, unspecified form		[1] Glucose 💬--[2] 86, 88 💬
31Access program - sildenafil citrate, Viagra, Revatio[1] Sildenafil[1] Sildenafil 💬[1] PDE5A 💬[3] Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬[1] 86 💬
32ACE-011----[1] 86 💬
33ACE-011 / MK - 7962----[1] 86 💬
34ACE-011 / MK-7962----[1] 86 💬
35ACE-011/ MK-7962----[1] 86 💬
36Acetamide[1] Acetamide---[2] 86, 154 💬
37Acetaminophen[1] Acetaminophen[1] Acetaminophen 💬[2] PTGS1,
PTGS2 💬		[23] Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬[13] 11, 13, 34, 35, 46, 49, 51, 70, 86, 222, 256, 271, 337 💬
38Acetate[1] Acetate---[41] 1, 2, 6, 10, 13, 46, 49, 51, 60, 64, 67, 70, 71, 73, 75, 76, 78, 79, 81, 83, 85, 86, 88, 90, 96, 97, 113, 145, 156, 171, 206, 222, 224, 225, 227, 235, 251, 265, 288, 298, 299 💬
39ACT - 064992----[1] 86 💬
40ACT-050089----[1] 86 💬
41ACT-050089 (Ro 61-0612)----[1] 86 💬
42ACT-064992----[5] 51, 85, 86, 88, 210 💬
43ACT-064992 / JNJ-67896062----[1] 86 💬
44ACT-064992/ JNJ-67896062----[1] 86 💬
45ACT-064992D----[1] 86 💬
46ACT-178418----[1] 86 💬
47ACT-293987----[3] 51, 86, 88 💬
48ACT-293987 (NS-304)----[1] 86 💬
49ACT-385781A----[1] 86 💬
50ACT-385781A (Actelion Epoprostenol)[1] Epoprostenol[1] Epoprostenol 💬[1] PTGIR 💬[3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬[1] 86 💬
51ActRIIA-IgG1Fc----[1] 86 💬
52Adcirca[1] Tadalafil[1] Tadalafil 💬[1] PDE5A 💬[3] Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬[1] 86 💬
53ADCIRCA 20 mg film-coated tablets[1] Tadalafil[1] Tadalafil 💬[1] PDE5A 💬[3] Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬[1] 86 💬
54Adcirca®[1] Tadalafil[1] Tadalafil 💬[1] PDE5A 💬[3] Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬[1] 86 💬
55Adempas[1] Riociguat[1] Riociguat 💬[3] GUCY1A1,
GUCY1A2,
GUCY1B1 💬		[11] Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬[5] 51, 86, 88, 225, 299 💬
56Adempas (Riociguat, BAY63-2521)[1] Riociguat[1] Riociguat 💬[3] GUCY1A1,
GUCY1A2,
GUCY1B1 💬		[11] Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬[2] 86, 88 💬
57ADEMPAS - 0,5 MG - COMPRESSA RIVESTITA CON FILM - USO ORALE - BLISTER (PP/ALU) - 42 COMPRESSE[1] Riociguat[1] Riociguat 💬[3] GUCY1A1,
GUCY1A2,
GUCY1B1 💬		[11] Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬[1] 86 💬
58ADEMPAS - 1 MG - COMPRESSA RIVESTITA CON FILM - USO ORALE - BLISTER (PP/ALU) - 42 COMPRESSE[1] Riociguat[1] Riociguat 💬[3] GUCY1A1,
GUCY1A2,
GUCY1B1 💬		[11] Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬[2] 51, 86 💬
59ADEMPAS - 1,5 MG - COMPRESSA RIVESTITA CON FILM - USO ORALE - BLISTER (PP/ALU) - 42 COMPRESSE[1] Riociguat[1] Riociguat 💬[3] GUCY1A1,
GUCY1A2,
GUCY1B1 💬		[11] Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬[2] 51, 86 💬
60ADEMPAS - 2 MG - COMPRESSA RIVESTITA CON FILM - USO ORALE - BLISTER (PP/ALU) - 42 COMPRESSE[1] Riociguat[1] Riociguat 💬[3] GUCY1A1,
GUCY1A2,
GUCY1B1 💬		[11] Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬[2] 51, 86 💬
61ADEMPAS - 2,5 MG - COMPRESSA RIVESTITA CON FILM - USO ORALE - BLISTER (PP/ALU) - 42 COMPRESSE[1] Riociguat[1] Riociguat 💬[3] GUCY1A1,
GUCY1A2,
GUCY1B1 💬		[11] Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬[2] 51, 86 💬
62Adempas 0.5 mg[1] Riociguat[1] Riociguat 💬[3] GUCY1A1,
GUCY1A2,
GUCY1B1 💬		[11] Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬[2] 86, 299 💬
63Adempas 0.5 mg Film Coated Tablet[1] Riociguat[1] Riociguat 💬[3] GUCY1A1,
GUCY1A2,
GUCY1B1 💬		[11] Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬[1] 86 💬
64Adempas 1 mg Film Coated Tablet[1] Riociguat[1] Riociguat 💬[3] GUCY1A1,
GUCY1A2,
GUCY1B1 💬		[11] Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬[1] 86 💬
65Adempas 1.0 mg[1] Riociguat[1] Riociguat 💬[3] GUCY1A1,
GUCY1A2,
GUCY1B1 💬		[11] Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬[2] 86, 299 💬
66Adempas 1.5 mg[1] Riociguat[1] Riociguat 💬[3] GUCY1A1,
GUCY1A2,
GUCY1B1 💬		[11] Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬[1] 86 💬
67Adempas 1.5 mg Film Coated Tablet[1] Riociguat[1] Riociguat 💬[3] GUCY1A1,
GUCY1A2,
GUCY1B1 💬		[11] Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬[1] 86 💬
68Adempas 2 mg Film Coated Tablet[1] Riociguat[1] Riociguat 💬[3] GUCY1A1,
GUCY1A2,
GUCY1B1 💬		[11] Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬[1] 86 💬
69Adempas 2.0 mg[1] Riociguat[1] Riociguat 💬[3] GUCY1A1,
GUCY1A2,
GUCY1B1 💬		[11] Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬[2] 86, 299 💬
70Adempas 2.5 mg[1] Riociguat[1] Riociguat 💬[3] GUCY1A1,
GUCY1A2,
GUCY1B1 💬		[11] Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬[1] 86 💬
71Adempas 2.5 mg Film Coated Tablet[1] Riociguat[1] Riociguat 💬[3] GUCY1A1,
GUCY1A2,
GUCY1B1 💬		[11] Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬[1] 86 💬
72Adempas®[1] Riociguat[1] Riociguat 💬[3] GUCY1A1,
GUCY1A2,
GUCY1B1 💬		[11] Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬[2] 86, 88 💬
73Adempas® 0.5 mg film-coated tablets[1] Riociguat[1] Riociguat 💬[3] GUCY1A1,
GUCY1A2,
GUCY1B1 💬		[11] Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬[1] 86 💬
74Adempas® 1.0 mg film-coated tablets[1] Riociguat[1] Riociguat 💬[3] GUCY1A1,
GUCY1A2,
GUCY1B1 💬		[11] Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬[1] 86 💬
75Adempas® 1.5 mg film-coated tablets[1] Riociguat[1] Riociguat 💬[3] GUCY1A1,
GUCY1A2,
GUCY1B1 💬		[11] Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬[1] 86 💬
76Adempas® 2.0 mg film-coated tablets[1] Riociguat[1] Riociguat 💬[3] GUCY1A1,
GUCY1A2,
GUCY1B1 💬		[11] Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬[1] 86 💬
77Adempas® 2.5 mg film-coated tablets[1] Riociguat[1] Riociguat 💬[3] GUCY1A1,
GUCY1A2,
GUCY1B1 💬		[11] Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬[1] 86 💬
78Adempas¿ 0.5 mg compressa rivestita con film[1] Riociguat[1] Riociguat 💬[3] GUCY1A1,
GUCY1A2,
GUCY1B1 💬		[11] Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬[1] 86 💬
79Adempas¿ 1.0[1] Riociguat[1] Riociguat 💬[3] GUCY1A1,
GUCY1A2,
GUCY1B1 💬		[11] Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬[1] 86 💬
80Adempas¿ 1.5 mg[1] Riociguat[1] Riociguat 💬[3] GUCY1A1,
GUCY1A2,
GUCY1B1 💬		[11] Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬[1] 86 💬
81Adempas¿ 2.0 mg[1] Riociguat[1] Riociguat 💬[3] GUCY1A1,
GUCY1A2,
GUCY1B1 💬		[11] Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬[1] 86 💬
82Adempas¿ 2.5 mg[1] Riociguat[1] Riociguat 💬[3] GUCY1A1,
GUCY1A2,
GUCY1B1 💬		[11] Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬[1] 86 💬
83Adipose derived mesenchymal stem cells----[1] 86 💬
84AER-901 Solution for Nebulization----[1] 86 💬
85Aerosolized iloprost[1] Iloprost[1] Iloprost 💬[1] PTGIR 💬[3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬[1] 86 💬
86AIR001----[1] 86 💬
87AIR001 (sodium nitrite inhalation solution)[1] Nitrite---[1] 86 💬
88AIR001 Inhalation Solution----[1] 86 💬
89AIR001 Inhalation Solution (Expansion arm)----[1] 86 💬
90AL----[11] 5, 6, 7, 13, 28, 51, 67, 86, 97, 114, 127 💬
91Albuterol[1] Salbutamol[1] Albuterol 💬[1] ADRB2 💬[9] Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[7] 12, 13, 86, 89, 113, 256, 299 💬
92Albuterol.[1] Salbutamol[1] Albuterol 💬[1] ADRB2 💬[9] Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 86 💬
93Allogeneic Human Cardiosphere-Derived Stem Cells----[1] 86 💬
94Ambrisentan[1] Ambrisentan[1] Ambrisentan 💬[1] EDNRA 💬[7] Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[7] 51, 84, 85, 86, 88, 210, 211 💬
95Ambrisentan - high dose[1] Ambrisentan[1] Ambrisentan 💬[1] EDNRA 💬[7] Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 86 💬
96Ambrisentan - low dose[1] Ambrisentan[1] Ambrisentan 💬[1] EDNRA 💬[7] Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 86 💬
97Ambrisentan 5 mg film-coated tablets[1] Ambrisentan[1] Ambrisentan 💬[1] EDNRA 💬[7] Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 86 💬
98Ambrisentan 5mg film-coated tablets [marketed product][1] Ambrisentan[1] Ambrisentan 💬[1] EDNRA 💬[7] Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 86 💬
99Ambrisentan plus Spironolactone[2] Ambrisentan,
Spironolactone		[2] Spironolactone ,
Ambrisentan 💬		[2] EDNRA,
NR3C2 💬		[8] Aldosterone-regulated sodium reabsorption, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 86 💬
100Ambrisentan Tablet[1] Ambrisentan[1] Ambrisentan 💬[1] EDNRA 💬[7] Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 86 💬
101AMN107----[2] 34, 86 💬
102Anakinra[1] Anakinra[1] Anakinra 💬[2] IL1R1,
IL1R2 💬		[15] Amoebiasis, Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Inflammatory mediator regulation of TRP channels, MAPK signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Pathogenic Escherichia coli infection, Prostate cancer, Shigellosis, Th17 cell differentiation, Transcriptional misregulation in cancer 💬[16] 2, 13, 15, 28, 37, 41, 46, 49, 50, 56, 84, 86, 97, 106, 107, 299 💬
103ANASTROZOLE[1] Anastrozole[1] Anastrozole 💬[1] CYP19A1 💬[3] Metabolic pathways, Ovarian steroidogenesis, Steroid hormone biosynthesis 💬[3] 78, 86, 193 💬
104Angiotensin[1] Angiotensin II[2] Angiotensin II ,
Angiotensin II 💬		[2] AGTR1,
AGTR2 💬		[16] AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬[7] 17, 19, 46, 66, 86, 222, 224 💬
105Apabetalone[1] Apabetalone[1] Apabetalone 💬[4] BRD2,
BRD3,
BRD4,
BRDT 💬		-[1] 86 💬
106APD811----[1] 86 💬
107Apelin----[1] 86 💬
108AR392830----[1] 86 💬
109Aspirin[1] Acetylsalicylic acid[1] Aspirin 💬[2] PTGS1,
PTGS2 💬		[23] Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬[12] 13, 22, 46, 49, 51, 58, 64, 86, 113, 158, 210, 231 💬
110Assigned pulmonary hypertension medication----[1] 86 💬
111Autologous EPCs transfected----[1] 86 💬
112Autologous EPCs transfected with human eNOS----[1] 86 💬
113AV-101[1] AV-101---[2] 6, 86 💬
114Aviptadil[1] Aviptadil[1] Aviptadil 💬--[5] 49, 51, 84, 85, 86 💬
115AZD4831----[1] 86 💬
116Background PAH Therapy----[1] 86 💬
117Bardoxolone[1] Bardoxolone[1] Bardoxolone 💬--[7] 66, 67, 84, 85, 86, 218, 222 💬
118Bardoxolone methyl[2] Bardoxolone,
Bardoxolone methyl		[2] Bardoxolone ,
Bardoxolone methyl 💬		--[7] 66, 67, 84, 85, 86, 218, 222 💬
119Bardoxolone methyl capsules[2] Bardoxolone,
Bardoxolone methyl		[2] Bardoxolone ,
Bardoxolone methyl 💬		--[4] 66, 67, 86, 222 💬
120BARDOXOLONE METHYL, CDDO-Me, CDDO-Methyl Ester, NSC 713200, Chemical Name: Oleana-1,9(11)-dien-28-oic acid, 2-cyano-3,12-dioxo-, methyl ester[2] Bardoxolone,
Bardoxolone methyl		[2] Bardoxolone ,
Bardoxolone methyl 💬		--[1] 86 💬
121BAY 63-2521----[2] 86, 88 💬
122BAY 63-2521 0.06 %----[1] 86 💬
123BAY 63-2521 0.3 %----[1] 86 💬
124BAY 63-2521 coated tablets 0.5 mg----[2] 86, 88 💬
125BAY 63-2521 coated tablets 1 mg----[2] 86, 88 💬
126BAY 63-2521 coated tablets 1.5 mg----[2] 86, 88 💬
127BAY 63-2521 coated tablets 2 mg----[2] 86, 88 💬
128BAY 63-2521 coated tablets 2.5 mg----[2] 86, 88 💬
129BAY 63-2521 IR tablets 0.5 mg----[1] 86 💬
130BAY 63-2521 IR tablets 1 mg----[1] 86 💬
131BAY 63-2521 IR tablets 1.0 mg----[1] 86 💬
132BAY 63-2521 IR tablets 1.5 mg----[1] 86 💬
133BAY 63-2521 IR tablets 2.0 mg----[1] 86 💬
134BAY 63-2521 IR tablets 2.5 mg----[1] 86 💬
135BAY 63-2521 Tablet----[1] 86 💬
136BAY 63-2521 tablets 0.5 mg----[2] 86, 88 💬
137BAY 63-2521 tablets 1 mg----[2] 86, 88 💬
138BAY 63-2521 tablets 1.5 mg----[2] 86, 88 💬
139BAY 63-2521 tablets 2 mg----[2] 86, 88 💬
140BAY 63-2521 tablets 2.5 mg----[2] 86, 88 💬
141Bay Q 6256----[1] 86 💬
142BAY1237592----[2] 86, 88 💬
143BAY63-2521----[3] 51, 86, 299 💬
144Beetroot juice----[2] 67, 86 💬
145Benzbromaron----[1] 86 💬
146Benzbromaron AL----[1] 86 💬
147BENZBROMARONE[1] Benzbromarone[1] Benzbromarone 💬[1] SLC22A12 💬-[1] 86 💬
148Beraprost[1] Beraprost[1] Beraprost 💬[1] PTGIR 💬[3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬[1] 86 💬
149Beraprost Sodium[1] Beraprost[1] Beraprost 💬[1] PTGIR 💬[3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬[1] 86 💬
150Beraprost Sodium 314d Modified Release Tablets[1] Beraprost[1] Beraprost 💬[1] PTGIR 💬[3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬[1] 86 💬
151Beraprost Sodium Modified Release[1] Beraprost[1] Beraprost 💬[1] PTGIR 💬[3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬[1] 86 💬
152BH4----[5] 51, 86, 124, 240, 299 💬
153BIA[1] BIA---[2] 6, 86 💬
154BIA 5-1058[1] BIA---[1] 86 💬
155BIA-5-1058[1] BIA---[1] 86 💬
156Biological DMARDs----[2] 86, 107 💬
157BISOPROLOL[1] Bisoprolol[1] Bisoprolol 💬[1] ADRB1 💬[11] Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[4] 58, 67, 86, 113 💬
158Bosentan[1] Bosentan[2] Bosentan ,
Bosentan 💬		[2] EDNRA,
EDNRB 💬		[9] Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[10] 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬
159Bosentan administration[1] Bosentan[2] Bosentan ,
Bosentan 💬		[2] EDNRA,
EDNRB 💬		[9] Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 86 💬
160Bosentan and Sildenafil[2] Bosentan,
Sildenafil		[3] Bosentan ,
Bosentan ,
Sildenafil 💬		[3] EDNRA,
EDNRB,
PDE5A 💬		[11] Calcium signaling pathway, Melanogenesis, Metabolic pathways, Neuroactive ligand-receptor interaction, Pathways in cancer, Purine metabolism, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 86 💬
161BOSENTAN MONOHIDRATO[1] Bosentan[2] Bosentan ,
Bosentan 💬		[2] EDNRA,
EDNRB 💬		[9] Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 86 💬
162Bosentan monohydrat[1] Bosentan[2] Bosentan ,
Bosentan 💬		[2] EDNRA,
EDNRB 💬		[9] Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 86 💬
163BOSENTAN MONOHYDRATE[1] Bosentan[2] Bosentan ,
Bosentan 💬		[2] EDNRA,
EDNRB 💬		[9] Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[4] 51, 84, 86, 88 💬
164Bosentan, Ambrisentan[2] Ambrisentan,
Bosentan		[3] Bosentan ,
Ambrisentan ,
Bosentan 💬		[2] EDNRA,
EDNRB 💬		[9] Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 86 💬
165BPS-314d-MR----[1] 86 💬
166BPS-MR----[1] 86 💬
167Bromure d'Ipratropium[1] Ipratropium---[1] 86 💬
168BSF 208075----[1] 86 💬
169BSF 208075 or LU 208075----[1] 86 💬
170C07AB07----[1] 86 💬
171C225----[2] 51, 86 💬
172Capsaicin[1] Capsaicin[1] Capsaicin 💬[1] TRPV1 💬[2] Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction 💬[3] 6, 86, 226 💬
173Captopril[1] Captopril[1] Captopril 💬[1] ACE 💬[6] Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system 💬[2] 17, 86 💬
174Carbon[1] Activated charcoal---[6] 6, 85, 86, 96, 97, 158 💬
175Carbon monoxide[2] Activated charcoal,
Carbon monoxide		[1] Carbon monoxide 💬--[2] 85, 86 💬
176Carnitine[1] Levocarnitine[1] Levocarnitine 💬--[9] 5, 13, 58, 86, 96, 97, 265, 298, 316 💬
177Carvedilol[1] Carvedilol[1] Carvedilol 💬[5] ADRA1A,
ADRA1B,
ADRA1D,
ADRB1,
ADRB2 💬		[13] AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[4] 57, 86, 113, 210 💬
178Cetuximab[1] Cetuximab[1] Cetuximab 💬[1] EGFR 💬[48] Adherens junction, Bladder cancer, Breast cancer, Calcium signaling pathway, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Coronavirus disease - COVID-19, Cushing syndrome, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endocytosis, Endometrial cancer, Epithelial cell signaling in Helicobacter pylori infection, ErbB signaling pathway, Estrogen signaling pathway, Focal adhesion, FoxO signaling pathway, Gap junction, Gastric cancer, Glioma, GnRH signaling pathway, HIF-1 signaling pathway, Hepatitis C, Hepatocellular carcinoma, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanoma, MicroRNAs in cancer, Non-small cell lung cancer, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Shigellosis 💬[2] 51, 86 💬
179Chlorhexidine[1] Chlorhexidine[1] Chlorhexidine 💬--[2] 86, 299 💬
180Cialis[1] Tadalafil[1] Tadalafil 💬[1] PDE5A 💬[3] Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬[2] 51, 86 💬
181Cialis 10 mg film-coated tablets[1] Tadalafil[1] Tadalafil 💬[1] PDE5A 💬[3] Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬[2] 86, 113 💬
182Cialis 2.5 mg film-coated tablets[1] Tadalafil[1] Tadalafil 💬[1] PDE5A 💬[3] Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬[2] 86, 113 💬
183CIALIS 20 mg comprimidos recubiertos con película[1] Tadalafil[1] Tadalafil 💬[1] PDE5A 💬[3] Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬[1] 86 💬
184Cialis 20 mg film-coated tablets[1] Tadalafil[1] Tadalafil 💬[1] PDE5A 💬[3] Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬[2] 86, 113 💬
185Cialis 5 mg film-coated tablets[1] Tadalafil[1] Tadalafil 💬[1] PDE5A 💬[3] Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬[2] 86, 113 💬
186Cicletanine[1] Cicletanine[1] Cicletanine 💬--[1] 86 💬
187Cicletanine hydrochloride[1] Cicletanine[1] Cicletanine 💬--[1] 86 💬
188Citrulline[1] Citrulline---[2] 86, 113 💬
189CJNJ-68150420-ZZZ-G001 (ACT- 064992D)----[1] 86 💬
190CJNJ-68150420-ZZZ-G001 (ACT-064992D)----[1] 86 💬
191CJNJ-68150420-ZZZ-G001(ACT-064992D)----[1] 86 💬
192Clopidogrel[1] Clopidogrel[3] Clopidogrel ,
Clopidogrel hydrochloride ,
Clopidogrel besilate 💬		[1] P2RY12 💬[1] Platelet activation 💬[3] 49, 51, 86 💬
193Coenzyme Q-10[1] Ubidecarenone[1] Ubidecarenone 💬--[1] 86 💬
194Coenzyme Q-10 in Normal Control subjects[1] Ubidecarenone[1] Ubidecarenone 💬--[1] 86 💬
195Coenzyme Q-10 in Pulmonary Hypertension subjects[1] Ubidecarenone[1] Ubidecarenone 💬--[1] 86 💬
196Combination Product:----[1] 86 💬
197Combination Product: Implantable System for Remodulin (treprostinil)[1] Treprostinil[1] Treprostinil 💬[1] PTGIR 💬[3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬[1] 86 💬
198Combination Product: Treprostinil via implanted pump[1] Treprostinil[1] Treprostinil 💬[1] PTGIR 💬[3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬[1] 86 💬
199Commercial Ventavis® (iloprost)[1] Iloprost[1] Iloprost 💬[1] PTGIR 💬[3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬[1] 86 💬
200Conivaptan[1] Conivaptan[1] Conivaptan 💬[2] AVPR1A,
AVPR2 💬		[5] Calcium signaling pathway, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vascular smooth muscle contraction, Vasopressin-regulated water reabsorption 💬[1] 86 💬
201Conventional drug therapy(expectorant,bronchodilator)----[1] 86 💬
202CosmoFer----[3] 86, 96, 97 💬
203CS1 Administration----[1] 86 💬
204Current marketed FLOLAN (epoprostenol sodium)[1] Epoprostenol[1] Epoprostenol 💬[1] PTGIR 💬[3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬[1] 86 💬
205CXA-10[1] CXA-10---[2] 86, 222 💬
206D-glucose[2] D-glucose,
Dextrose, unspecified form		[1] Glucose 💬--[3] 49, 86, 88 💬
207D.3.6.2 - dose massima specificare: giornaliera----[1] 86 💬
208Dapagliflozin[1] Dapagliflozin[1] Dapagliflozin 💬[1] SLC5A2 💬-[7] 19, 49, 66, 67, 86, 88, 222 💬
209Dapagliflozin 10 MG [Farxiga][1] Dapagliflozin[1] Dapagliflozin 💬[1] SLC5A2 💬-[2] 86, 88 💬
210DHEA[1] Prasterone[1] Prasterone 💬[3] AR,
ESR1,
ESR2 💬		[12] Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Oocyte meiosis, Pathways in cancer, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬[3] 49, 86, 96 💬
211DHEA tablet[1] Prasterone[1] Prasterone 💬[3] AR,
ESR1,
ESR2 💬		[12] Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Oocyte meiosis, Pathways in cancer, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬[1] 86 💬
212Dichloroacetate[1] Dichloroacetic acid---[1] 86 💬
213Dichloroacetate Sodium[2] Dichloroacetic acid,
Sodium dichloroacetate		[1] Sodium dichloroacetate 💬[3] PDK2,
PDK3,
PDK4 💬		[1] Diabetic cardiomyopathy 💬[1] 86 💬
214Diet----[4] 86, 97, 240, 299 💬
215Dietanolamina de treprostinilo[1] Treprostinil[1] Treprostinil 💬[1] PTGIR 💬[3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬[1] 86 💬
216Diltiazem[1] Diltiazem[1] Diltiazem 💬[4] CACNA1C,
CACNA1D,
CACNA1F,
CACNA1S 💬		[37] Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[3] 51, 58, 86 💬
217Diltiazem Hydrochloride[1] Diltiazem[1] Diltiazem 💬[4] CACNA1C,
CACNA1D,
CACNA1F,
CACNA1S 💬		[37] Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 86 💬
218DIMETHYL FUMARATE[1] Dimethyl fumarate[1] Dimethyl fumarate 💬[1] KEAP1 💬[6] Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Parkinson disease, Pathways in cancer, Ubiquitin mediated proteolysis 💬[4] 13, 51, 86, 296 💬
219Dimethyl Fumarate (DMF)[1] Dimethyl fumarate[1] Dimethyl fumarate 💬[1] KEAP1 💬[6] Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Parkinson disease, Pathways in cancer, Ubiquitin mediated proteolysis 💬[3] 13, 51, 86 💬
220Diphenhydramine[1] Diphenhydramine[1] Diphenhydramine 💬[1] HRH1 💬[3] Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction 💬[8] 11, 13, 49, 51, 70, 86, 222, 256 💬
221Dobutamine[1] Dobutamine[1] Dobutamine 💬[1] ADRB1 💬[11] Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[4] 57, 58, 86, 215 💬
222Dobutamine test[1] Dobutamine[1] Dobutamine 💬[1] ADRB1 💬[11] Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 86 💬
223Duo-Therapy with Sildenafil + Bosentan[2] Bosentan,
Sildenafil		[3] Bosentan ,
Bosentan ,
Sildenafil 💬		[3] EDNRA,
EDNRB,
PDE5A 💬		[11] Calcium signaling pathway, Melanogenesis, Metabolic pathways, Neuroactive ligand-receptor interaction, Pathways in cancer, Purine metabolism, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 86 💬
224EFI/ACT-385781A----[1] 86 💬
225Elafin[1] Elafin---[1] 86 💬
226Endothelin receptor antagonist therapy----[1] 86 💬
227Endothelin Receptor Antagonists----[1] 86 💬
228Endothelin-3----[1] 86 💬
229ENOS transfected EPCs will be delivered via a PA line----[1] 86 💬
230Epicatechin[1] Epicatechin---[2] 86, 113 💬
231EPOPROSTENOL[1] Epoprostenol[1] Epoprostenol 💬[1] PTGIR 💬[3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬[1] 86 💬
232Epoprostenol for injection[1] Epoprostenol[1] Epoprostenol 💬[1] PTGIR 💬[3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬[1] 86 💬
233EPOPROSTENOL SODICO[1] Epoprostenol[1] Epoprostenol 💬[1] PTGIR 💬[3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬[1] 86 💬
234EPOPROSTENOL SODIUM[1] Epoprostenol[1] Epoprostenol 💬[1] PTGIR 💬[3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬[1] 86 💬
235Epoprostenol-Actelion[1] Epoprostenol[1] Epoprostenol 💬[1] PTGIR 💬[3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬[1] 86 💬
236Epoprostenolo per iniezione----[1] 86 💬
237Equal----[4] 6, 13, 67, 86 💬
238ERA and PDE-5I (Sildenafil, Tadalafil, Bosentan, Macitentan)[4] Bosentan,
Macitentan,
Sildenafil,
Tadalafil		[5] Bosentan ,
Tadalafil ,
Bosentan ,
Sildenafil ,
Macitentan 💬		[3] EDNRA,
EDNRB,
PDE5A 💬		[11] Calcium signaling pathway, Melanogenesis, Metabolic pathways, Neuroactive ligand-receptor interaction, Pathways in cancer, Purine metabolism, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 86 💬
239ERA as specific PAH treatment----[1] 86 💬
240Erbitux[1] Cetuximab[1] Cetuximab 💬[1] EGFR 💬[48] Adherens junction, Bladder cancer, Breast cancer, Calcium signaling pathway, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Coronavirus disease - COVID-19, Cushing syndrome, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endocytosis, Endometrial cancer, Epithelial cell signaling in Helicobacter pylori infection, ErbB signaling pathway, Estrogen signaling pathway, Focal adhesion, FoxO signaling pathway, Gap junction, Gastric cancer, Glioma, GnRH signaling pathway, HIF-1 signaling pathway, Hepatitis C, Hepatocellular carcinoma, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanoma, MicroRNAs in cancer, Non-small cell lung cancer, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Shigellosis 💬[2] 51, 86 💬
241Esomeprazole[1] Esomeprazole[1] Esomeprazole 💬[2] ATP4A,
ATP4B 💬		[4] Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation 💬[8] 13, 46, 86, 98, 107, 113, 298, 299 💬
242ESR-specific PET scan----[1] 86 💬
243Esuberaprost----[1] 86 💬
244Eutonic Treprostinil Solution[1] Treprostinil[1] Treprostinil 💬[1] PTGIR 💬[3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬[1] 86 💬
245Famotidine[1] Famotidine[1] Famotidine 💬[1] HRH2 💬[3] Calcium signaling pathway, Gastric acid secretion, Neuroactive ligand-receptor interaction 💬[5] 6, 46, 86, 98, 107 💬
246Famotidine 20 MG[1] Famotidine[1] Famotidine 💬[1] HRH2 💬[3] Calcium signaling pathway, Gastric acid secretion, Neuroactive ligand-receptor interaction 💬[1] 86 💬
247FDC macitentan/tadalafil[2] Macitentan,
Tadalafil		[2] Tadalafil ,
Macitentan 💬		[3] EDNRA,
EDNRB,
PDE5A 💬		[11] Calcium signaling pathway, Melanogenesis, Metabolic pathways, Neuroactive ligand-receptor interaction, Pathways in cancer, Purine metabolism, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 86 💬
248Ferinject----[2] 86, 299 💬
249Ferinject or CosmoFer----[1] 86 💬
250FERRIC CARBOXYMALTOSE[1] Ferric carboxymaltose[1] Ferric carboxymaltose 💬--[4] 86, 96, 97, 299 💬
251Ferricarboxymaltose----[1] 86 💬
252FK506 level 2-3 ng/ml----[1] 86 💬
253FK506 level 3-5 ng/ml----[1] 86 💬
254FK506 level < 2 ng/ml----[1] 86 💬
255Flolan[1] Epoprostenol[1] Epoprostenol 💬[1] PTGIR 💬[3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬[1] 86 💬
256FLOLAN injection with currently marketed diluent[1] Epoprostenol[1] Epoprostenol 💬[1] PTGIR 💬[3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬[1] 86 💬
257FLOLAN injection with reformulated diluent[1] Epoprostenol[1] Epoprostenol 💬[1] PTGIR 💬[3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬[1] 86 💬
258FLOLAN TM and Glycine Diluent[2] Epoprostenol,
Glycine		[2] Glycine ,
Epoprostenol 💬		[1] PTGIR 💬[3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬[1] 86 💬
259Flolan®[1] Epoprostenol[1] Epoprostenol 💬[1] PTGIR 💬[3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬[1] 86 💬
260FLOLAN™ and Glycine Diluent[2] Epoprostenol,
Glycine		[2] Glycine ,
Epoprostenol 💬		[1] PTGIR 💬[3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬[1] 86 💬
261FLUOXETINE[1] Fluoxetine[1] Fluoxetine 💬[1] SLC6A4 💬[2] Serotonergic synapse, Synaptic vesicle cycle 💬[4] 13, 17, 78, 86 💬
262Forxiga[1] Dapagliflozin[1] Dapagliflozin 💬[1] SLC5A2 💬-[2] 86, 88 💬
263Forxiga (dapagliflozin)[1] Dapagliflozin[1] Dapagliflozin 💬[1] SLC5A2 💬-[2] 86, 88 💬
264Fulvestrant[1] Fulvestrant[1] Fulvestrant 💬[2] ESR1,
ESR2 💬		[10] Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬[1] 86 💬
265Furosemide[1] Furosemide[1] Furosemide 💬[1] SLC12A2 💬[3] Pancreatic secretion, Salivary secretion, Vibrio cholerae infection 💬[2] 6, 86 💬
266G04BE03----[1] 86 💬
267G04BE03- Sildenafil - sildenafil (citrato)[1] Sildenafil[1] Sildenafil 💬[1] PDE5A 💬[3] Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬[1] 86 💬
268G04BE08----[1] 86 💬
269GB002----[1] 86 💬
270GB002 (seralutinib)----[1] 86 💬
271GB002 Capsules----[1] 86 💬
272GLIVEC[1] Imatinib[1] Imatinib 💬[3] ABL1,
KIT,
PDGFRA 💬		[32] Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 💬[2] 51, 86 💬
273GLIVEC 100 mg comprimidos recubiertos con película[1] Imatinib[1] Imatinib 💬[3] ABL1,
KIT,
PDGFRA 💬		[32] Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 💬[2] 34, 86 💬
274Glivec 100 mg Filmtabletten[1] Imatinib[1] Imatinib 💬[3] ABL1,
KIT,
PDGFRA 💬		[32] Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 💬[2] 51, 86 💬
275Glivec 100 mg Hartkapsel[1] Imatinib[1] Imatinib 💬[3] ABL1,
KIT,
PDGFRA 💬		[32] Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 💬[1] 86 💬
276Glivec®[1] Imatinib[1] Imatinib 💬[3] ABL1,
KIT,
PDGFRA 💬		[32] Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 💬[1] 86 💬
277Glivec® 100 mg Filmtabletten[1] Imatinib[1] Imatinib 💬[3] ABL1,
KIT,
PDGFRA 💬		[32] Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 💬[1] 86 💬
278Glucose[2] D-glucose,
Dextrose, unspecified form		[1] Glucose 💬--[12] 2, 6, 13, 49, 50, 66, 86, 88, 96, 97, 257, 299 💬
279GLYCINE[1] Glycine[1] Glycine 💬--[5] 35, 60, 86, 226, 299 💬
280GMA301 Injection----[1] 86 💬
281Gold[1] Gold---[43] 2, 5, 6, 13, 17, 34, 35, 46, 49, 50, 53, 58, 63, 65, 68, 76, 84, 86, 91, 93, 95, 96, 97, 98, 113, 137, 158, 162, 167, 171, 193, 218, 222, 224, 226, 227, 230, 271, 291, 296, 298, 310, 318 💬
282GS-4997 18 mg----[1] 86 💬
283GS-4997 2 mg----[1] 86 💬
284GS-4997 6 mg----[1] 86 💬
285GSK1325760----[2] 86, 88 💬
286GSK1325760A----[1] 86 💬
287GSK2256098[1] GSK2256098---[1] 86 💬
288GSK2586881----[1] 86 💬
289HGP1206----[1] 86 💬
290Hydroxyurea[1] Hydroxyurea[1] Hydroxyurea 💬[1] RRM2 💬[7] Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism, p53 signaling pathway 💬[8] 3, 13, 19, 20, 65, 85, 86, 284 💬
291Hyperpolarized 129Xe----[1] 86 💬
292Hyperpolarized Xe129----[4] 51, 85, 86, 299 💬
293HypotonicTreprostinil Solution----[1] 86 💬
294I.v. selexipag[1] Selexipag[1] Selexipag 💬[1] PTGIR 💬[3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬[1] 86 💬
295Ilomedin 20----[1] 86 💬
296Ilomedin 20 [20 µg / ml]----[1] 86 💬
297Iloprost[1] Iloprost[1] Iloprost 💬[1] PTGIR 💬[3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬[4] 51, 84, 85, 86 💬
298Iloprost (5 µg)[1] Iloprost[1] Iloprost 💬[1] PTGIR 💬[3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬[1] 86 💬
299Iloprost (Ventavis BAYQ6256)[1] Iloprost[1] Iloprost 💬[1] PTGIR 💬[3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬[1] 86 💬
300Iloprost (Ventavis inhaled, BAYQ6256)[1] Iloprost[1] Iloprost 💬[1] PTGIR 💬[3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬[1] 86 💬
301Iloprost (Ventavis, BAYQ 6256)[1] Iloprost[1] Iloprost 💬[1] PTGIR 💬[3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬[1] 86 💬
302Iloprost (Ventavis, BAYQ6256)[1] Iloprost[1] Iloprost 💬[1] PTGIR 💬[3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬[1] 86 💬
303Iloprost (Ventavis®)[1] Iloprost[1] Iloprost 💬[1] PTGIR 💬[3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬[1] 86 💬
304Iloprost Inhalation Solution (Ventavis)[1] Iloprost[1] Iloprost 💬[1] PTGIR 💬[3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬[2] 85, 86 💬
305Iloprost PD-15[1] Iloprost[1] Iloprost 💬[1] PTGIR 💬[3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬[1] 86 💬
306Iloprost PD-6[1] Iloprost[1] Iloprost 💬[1] PTGIR 💬[3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬[1] 86 💬
307Iloprost,(Ventavis, BAYQ6256)[1] Iloprost[1] Iloprost 💬[1] PTGIR 💬[3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬[1] 86 💬
308Imatinib[1] Imatinib[1] Imatinib 💬[3] ABL1,
KIT,
PDGFRA 💬		[32] Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 💬[12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
309IMATINIB MESILATE[1] Imatinib[1] Imatinib 💬[3] ABL1,
KIT,
PDGFRA 💬		[32] Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 💬[3] 13, 86, 88 💬
310Imatinib Mesylate[1] Imatinib[1] Imatinib 💬[3] ABL1,
KIT,
PDGFRA 💬		[32] Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 💬[5] 13, 28, 34, 51, 86 💬
311Inhaled dry powder treprostinil (LIQ861)[1] Treprostinil[1] Treprostinil 💬[1] PTGIR 💬[3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬[1] 86 💬
312Inhaled Iloprost (5 µg)[1] Iloprost[1] Iloprost 💬[1] PTGIR 💬[3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬[1] 86 💬
313Inhaled iloprost (Ventavis, BAYQ6256)[1] Iloprost[1] Iloprost 💬[1] PTGIR 💬[3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬[1] 86 💬
314Inhaled Nitric Oxide[1] Nitric Oxide[1] Nitric oxide 💬--[2] 85, 86 💬
315Inhaled nitric oxide & INOpulse delivery[1] Nitric Oxide[1] Nitric oxide 💬--[1] 86 💬
316Inhaled nitric oxide 75 mcg/kg IBW/hr[1] Nitric Oxide[1] Nitric oxide 💬--[2] 85, 86 💬
317Inhaled NO with pulsed delivery----[1] 86 💬
318Inhaled prostacyclin[1] Epoprostenol[1] Epoprostenol 💬[1] PTGIR 💬[3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬[1] 86 💬
319Inhaled Treprostinil[1] Treprostinil[1] Treprostinil 💬[1] PTGIR 💬[3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬[3] 84, 85, 86 💬
320INO----[2] 85, 86 💬
321Intestinal microbiota transplant (IMT)----[1] 86 💬
322Intravenous administration of ferric carboxymaltose[1] Ferric carboxymaltose[1] Ferric carboxymaltose 💬--[1] 86 💬
323Intravenous Treprostinil[1] Treprostinil[1] Treprostinil 💬[1] PTGIR 💬[3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬[1] 86 💬
324Ipratropium[1] Ipratropium---[2] 6, 86 💬
325Iron supplement----[1] 86 💬
326JNJ-67896049----[1] 86 💬
327JNJ-67896049 (ACT-293987)----[1] 86 💬
328JNJ-67896062 / ACT-064992----[2] 86, 88 💬
329JNJ-67896062/ ACT-064992----[2] 86, 88 💬
330JNJ-67896062/ACT-064922----[1] 86 💬
331JTT-251----[1] 86 💬
332KAR5585 Capsules----[1] 86 💬
333L-Carnitine[1] Levocarnitine[1] Levocarnitine 💬--[7] 13, 86, 96, 97, 265, 298, 316 💬
334L-Citrulline Malate[1] Citrulline---[1] 86 💬
335L606 (Liposomal Treprostinil) Inhalation Solution 51ug[1] Treprostinil[1] Treprostinil 💬[1] PTGIR 💬[3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬[1] 86 💬
336Levitra[1] Vardenafil[1] Vardenafil 💬[1] PDE5A 💬[3] Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬[2] 13, 86 💬
337Lidocaine[1] Lidocaine[2] Lidocaine ,
Lidocaine hydrochloride monohydrate 💬		[5] SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬		[3] Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬[12] 6, 13, 22, 34, 46, 51, 70, 86, 107, 168, 226, 256 💬
338LIQ861 100 µg----[1] 86 💬
339LIQ861 106 µg----[1] 86 💬
340LIQ861 25 µg----[1] 86 💬
341LIQ861 26.5 µg----[1] 86 💬
342LIQ861 50 µg----[1] 86 💬
343LIQ861 53 µg----[1] 86 💬
344LIQ861 75 µg----[1] 86 💬
345LIQ861 79.5 µg----[1] 86 💬
346LIQ861 Inhaled Treprostinil[1] Treprostinil[1] Treprostinil 💬[1] PTGIR 💬[3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬[1] 86 💬
347LISURIDE[1] Lisuride[1] Lisuride 💬[3] DRD2,
DRD3,
DRD4 💬		[8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[2] 6, 86 💬
348Lloprost(Ventavis,BAYQ6252, 10 µg/mL)[1] Iloprost[1] Iloprost 💬[1] PTGIR 💬[3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬[1] 86 💬
349Lloprost(Ventavis,BAYQ6252, 20 µg/mL)[1] Iloprost[1] Iloprost 💬[1] PTGIR 💬[3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬[1] 86 💬
350LTP001----[2] 85, 86 💬
351LY450190----[1] 86 💬
352Macitentan[1] Macitentan[1] Macitentan 💬[2] EDNRA,
EDNRB 💬		[9] Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[5] 51, 85, 86, 88, 210 💬
353Macitentan (ACT-064992)[1] Macitentan[1] Macitentan 💬[2] EDNRA,
EDNRB 💬		[9] Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 86 💬
354Macitentan 10 mg[1] Macitentan[1] Macitentan 💬[2] EDNRA,
EDNRB 💬		[9] Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[3] 51, 86, 88 💬
355Macitentan 10 mg tablet, once daily.[1] Macitentan[1] Macitentan 💬[2] EDNRA,
EDNRB 💬		[9] Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 86 💬
356Macitentan 37.5 mg[1] Macitentan[1] Macitentan 💬[2] EDNRA,
EDNRB 💬		[9] Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 86 💬
357Macitentan 75 mg[1] Macitentan[1] Macitentan 💬[2] EDNRA,
EDNRB 💬		[9] Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 86 💬
358MACITENTAN COMPRESSE[1] Macitentan[1] Macitentan 💬[2] EDNRA,
EDNRB 💬		[9] Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[2] 86, 88 💬
359Macitentan Group[1] Macitentan[1] Macitentan 💬[2] EDNRA,
EDNRB 💬		[9] Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 86 💬
360MACITENTAN TABLETS[1] Macitentan[1] Macitentan 💬[2] EDNRA,
EDNRB 💬		[9] Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[2] 86, 88 💬
361MD-711----[1] 86 💬
362Medical air[2] Medical air,
Oxygen		[1] Oxygen 💬--[3] 85, 86, 193 💬
363Metformin[1] Metformin[1] Metformin 💬[2] PRKAA1,
PRKAA2 💬		[20] AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬[25] 2, 6, 8, 13, 46, 49, 60, 65, 67, 75, 77, 81, 86, 97, 113, 127, 158, 206, 218, 225, 233, 265, 285, 299, 301 💬
364Methyl 4,6-diamino-2-[1-(2-fluorobenzyl)-1H-pyrazolo----[1] 86 💬
365Methyl 4,6-diamino-2-[1-(2-fluorobenzyl)-1H-pyrazolo [3,4-b]pyridine-3-yl]-5-pyrimidinyl(methyl)carb----[2] 86, 88 💬
366Methyl [4,6-diamino-2-[1-[(2-fluorophenyl)methyl]-1H-pyrazolo[3,4-b]pyridin-3-yl]-5-pyrimidinyl]meth----[2] 86, 88 💬
367Methylprednisolone[1] Methylprednisolone[1] Methylprednisolone 💬[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[46] 2, 11, 13, 14, 18, 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 51, 60, 62, 63, 64, 65, 66, 83, 84, 85, 86, 93, 95, 96, 97, 145, 162, 164, 211, 220, 222, 224, 271, 283, 284, 285, 296 💬
368MK-4836----[2] 86, 88 💬
369MK-5475----[1] 86 💬
370MK-7962----[1] 86 💬
371MK-8892----[1] 86 💬
372MN-08 24 mg/day----[1] 86 💬
373MN-08 60 mg/day----[1] 86 💬
374Mono-Therapy with Sildenafil[1] Sildenafil[1] Sildenafil 💬[1] PDE5A 💬[3] Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬[1] 86 💬
375Morphine[1] Morphine[1] Morphine 💬[1] OPRM1 💬[3] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction 💬[5] 36, 46, 70, 85, 86 💬
376MORPHINE SULFATE[2] Morphine,
Sulfate ion		[1] Morphine 💬[1] OPRM1 💬[3] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction 💬[3] 46, 85, 86 💬
377Moxifloxacin[1] Moxifloxacin[1] Moxifloxacin 💬--[9] 2, 6, 46, 49, 85, 86, 113, 240, 299 💬
378Moxifloxacin 400 mg[1] Moxifloxacin[1] Moxifloxacin 💬--[1] 86 💬
379MultiHance[1] Gadobenic acid[1] Gadobenic acid 💬--[2] 86, 88 💬
380Nab-sirolimus (also known as ABI-009, nab-rapamycin, albumin-bound rapamycin)[1] Sirolimus[1] Sirolimus 💬[1] MTOR 💬[51] AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬[1] 86 💬
381Nebulized combination ipratropium bromide with salbutamol[2] Ipratropium,
Salbutamol		[1] Albuterol 💬[1] ADRB2 💬[9] Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 86 💬
382Nebulized ipratropium bromide[1] Ipratropium---[1] 86 💬
383New thermo stable formulation of epoprostenol sodium[1] Epoprostenol[1] Epoprostenol 💬[1] PTGIR 💬[3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬[1] 86 💬
384Nicardipine[1] Nicardipine[1] Nicardipine 💬[4] CACNA1C,
CACNA1D,
CACNA1F,
CACNA1S 💬		[37] Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[2] 70, 86 💬
385Nilotinib[1] Nilotinib[1] Nilotinib 💬[4] ABL1,
KIT,
PDGFRA,
PDGFRB 💬		[33] Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 💬[5] 6, 8, 34, 51, 86 💬
386Nilotinib 50 mg[1] Nilotinib[1] Nilotinib 💬[4] ABL1,
KIT,
PDGFRA,
PDGFRB 💬		[33] Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 💬[1] 86 💬
387NITRIC OXIDE[1] Nitric Oxide[1] Nitric oxide 💬--[7] 85, 86, 88, 210, 251, 294, 299 💬
388Nitric Oxide for inhalation[1] Nitric Oxide[1] Nitric oxide 💬--[2] 86, 299 💬
389Nitric Oxide generated by the GeNO nitrosyl delivery system[1] Nitric Oxide[1] Nitric oxide 💬--[1] 86 💬
390Nitric Oxide plus Oxygen[2] Nitric Oxide,
Oxygen		[2] Oxygen ,
Nitric oxide 💬		--[1] 86 💬
391Nitrite[1] Nitrite---[2] 58, 86 💬
392Nitrosyl[1] Nitric Oxide[1] Nitric oxide 💬--[1] 86 💬
393NO----[9] 6, 46, 58, 62, 86, 97, 222, 299, 321 💬
394Non-Biologic DMARDs----[3] 46, 86, 107 💬
395NS-304----[3] 70, 86, 88 💬
396Null----[16] 6, 13, 15, 28, 37, 46, 49, 51, 63, 86, 90, 96, 97, 107, 145, 271 💬
397NX1011----[1] 86 💬
398Observational study with patients treated with Tracleer, Ventavis, Veletri, Opsumit and/or Uptravi[4] Epoprostenol,
Iloprost,
Macitentan,
Selexipag		[4] Epoprostenol ,
Iloprost ,
Selexipag ,
Macitentan 💬		[3] EDNRA,
EDNRB,
PTGIR 💬		[10] Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Platelet activation, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 86 💬
399Olaparib[1] Olaparib[1] Olaparib 💬[2] PARP1,
PARP2 💬		[5] Apoptosis, Base excision repair, Diabetic cardiomyopathy, NF-kappa B signaling pathway, Necroptosis 💬[2] 86, 285 💬
400Opsumit[1] Macitentan[1] Macitentan 💬[2] EDNRA,
EDNRB 💬		[9] Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[3] 86, 88, 210 💬
401Opsumit (macitentan)[1] Macitentan[1] Macitentan 💬[2] EDNRA,
EDNRB 💬		[9] Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 86 💬
402Opsumit®[1] Macitentan[1] Macitentan 💬[2] EDNRA,
EDNRB 💬		[9] Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[3] 86, 88, 210 💬
403Oral anticoagulant treatment----[1] 86 💬
404Oral ERA----[1] 86 💬
405Oral PDE5 inhibitors----[1] 86 💬
406Oral selexipag (Uptravi)[1] Selexipag[1] Selexipag 💬[1] PTGIR 💬[3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬[1] 86 💬
407Oral sildenafil[1] Sildenafil[1] Sildenafil 💬[1] PDE5A 💬[3] Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬[1] 86 💬
408Oral treprostinil[1] Treprostinil[1] Treprostinil 💬[1] PTGIR 💬[3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬[2] 51, 86 💬
409Oral treprostinil (UT-15C) Sustained Release Tablets[1] Treprostinil[1] Treprostinil 💬[1] PTGIR 💬[3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬[1] 86 💬
410Ossido Nitrico----[1] 86 💬
411Oxygen[1] Oxygen[1] Oxygen 💬--[13] 6, 49, 70, 85, 86, 88, 90, 96, 168, 193, 271, 299, 330 💬
412Oxygen supplementation[1] Oxygen[1] Oxygen 💬--[1] 86 💬
413Oxygen, liquid[1] Oxygen[1] Oxygen 💬--[2] 86, 88 💬
414PAH----[3] 49, 53, 86 💬
415PAH medication----[1] 86 💬
416PAH Therapies----[1] 86 💬
417Parenteral Remodulin (treprostinil) injection[1] Treprostinil[1] Treprostinil 💬[1] PTGIR 💬[3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬[1] 86 💬
418Parenteral Treprostinil[1] Treprostinil[1] Treprostinil 💬[1] PTGIR 💬[3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬[1] 86 💬
419PB1046----[1] 86 💬
420PB1046 Subcutaneous Injection----[1] 86 💬
421PB1046, VIP-ELP1-120, Vasomera----[1] 86 💬
422PDE5 inhibitor----[1] 86 💬
423Pemziviptadil (PB1046) Injection----[1] 86 💬
424Pentoxifylline[1] Pentoxifylline[1] Pentoxifylline 💬--[12] 26, 56, 84, 86, 93, 96, 97, 113, 220, 222, 296, 298 💬
425PF-00489791[1] PF-00489791---[1] 86 💬
426Pioglitazone[1] Pioglitazone[1] Pioglitazone 💬[1] PPARG 💬[11] AMPK signaling pathway, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬[17] 2, 6, 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299 💬
427Placebo----[28] 3, 5, 6, 11, 13, 14, 37, 40, 46, 49, 50, 51, 53, 63, 66, 67, 79, 85, 86, 88, 96, 97, 140, 144, 149, 226, 271, 276 💬
428PLX-PAD[1] Placental Mesenchymal Stem Cells---[1] 86 💬
429Prednisone[1] Prednisone[1] Prednisone 💬[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[45] 2, 11, 13, 14, 19, 26, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 61, 63, 64, 65, 66, 79, 81, 84, 85, 86, 95, 96, 97, 113, 162, 164, 205, 222, 224, 228, 283, 284, 288, 299, 300, 307, 331 💬
430Prostacyclin[1] Epoprostenol[1] Epoprostenol 💬[1] PTGIR 💬[3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬[1] 86 💬
431Prostacyclin Receptor Agonist[1] Epoprostenol[1] Epoprostenol 💬[1] PTGIR 💬[3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬[1] 86 💬
432Puri-Nethol----[3] 86, 96, 97 💬
433Q4W GMA301 IV injections (1000 mg)----[1] 86 💬
434Q4W GMA301 IV injections (300 mg)----[1] 86 💬
435Q4W GMA301 IV injections (600 mg)----[1] 86 💬
436QCC374----[1] 86 💬
437QCC374 0.015 mg----[1] 86 💬
438QCC374 0.06 mg----[1] 86 💬
439QTI571----[1] 86 💬
440Qutenza[1] Capsaicin[1] Capsaicin 💬[1] TRPV1 💬[2] Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction 💬[1] 86 💬
441Qutenza (8% capsaicin)[1] Capsaicin[1] Capsaicin 💬[1] TRPV1 💬[2] Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction 💬[1] 86 💬
442RALINEPAG[1] Ralinepag[1] Ralinepag 💬[1] PTGIR 💬[3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬[1] 86 💬
443Ranolazine[1] Ranolazine[1] Ranolazine 💬--[6] 2, 58, 86, 96, 113, 114 💬
444Rapamycin[1] Sirolimus[1] Sirolimus 💬[1] MTOR 💬[51] AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬[18] 15, 34, 35, 46, 49, 51, 53, 60, 61, 67, 86, 89, 96, 157, 158, 193, 256, 279 💬
445Rapid Dose Titration Group of Subcutaneous Treprostinil[1] Treprostinil[1] Treprostinil 💬[1] PTGIR 💬[3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬[1] 86 💬
446Recombinant Human Angiotensin-Converting Enzyme 2[2] Alunacedase alfa,
Angiotensin II		[2] Angiotensin II ,
Angiotensin II 💬		[2] AGTR1,
AGTR2 💬		[16] AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬[1] 86 💬
447Recombinant Human Angiotensin-converting enzyme 2 (ACE2), APN01[2] Alunacedase alfa,
Angiotensin II		[2] Angiotensin II ,
Angiotensin II 💬		[2] AGTR1,
AGTR2 💬		[16] AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬[1] 86 💬
448Remodulin[1] Treprostinil[1] Treprostinil 💬[1] PTGIR 💬[3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬[2] 86, 88 💬
449Remodulin (treprostinil sodium)[1] Treprostinil[1] Treprostinil 💬[1] PTGIR 💬[3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬[1] 86 💬
450Remodulin® (treprostinil) 1 mg/ml solution for infusion[1] Treprostinil[1] Treprostinil 💬[1] PTGIR 💬[3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬[1] 86 💬
451Remodulin® (treprostinil) 10 mg/ml solution for infusion[1] Treprostinil[1] Treprostinil 💬[1] PTGIR 💬[3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬[1] 86 💬
452Remodulin® (treprostinil) 2.5 mg/ml solution for infusion[1] Treprostinil[1] Treprostinil 💬[1] PTGIR 💬[3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬[1] 86 💬
453Remodulin® (treprostinil) 5 mg/ml solution for infusion[1] Treprostinil[1] Treprostinil 💬[1] PTGIR 💬[3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬[1] 86 💬
454Revatio[1] Sildenafil[1] Sildenafil 💬[1] PDE5A 💬[3] Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬[3] 85, 86, 113 💬
455Revatio 10 mg/ml powder for oral suspension[1] Sildenafil[1] Sildenafil 💬[1] PDE5A 💬[3] Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬[1] 86 💬
456Revatio 20 mg film coated tablets[1] Sildenafil[1] Sildenafil 💬[1] PDE5A 💬[3] Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬[1] 86 💬
457Revatio 20 mg film-coated tablets----[1] 86 💬
458Revatio 20 mg Filmtabletten[1] Sildenafil[1] Sildenafil 💬[1] PDE5A 💬[3] Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬[1] 86 💬
459REVATIO 20 mg, comprimidos recubiertos con película[1] Sildenafil[1] Sildenafil 💬[1] PDE5A 💬[3] Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬[1] 86 💬
460Revatio inyectable[1] Sildenafil[1] Sildenafil 💬[1] PDE5A 💬[3] Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬[1] 86 💬
461Revatio oral[1] Sildenafil[1] Sildenafil 💬[1] PDE5A 💬[3] Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬[1] 86 💬
462Revatio POS[1] Sildenafil[1] Sildenafil 💬[1] PDE5A 💬[3] Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬[1] 86 💬
463Revatio Tablets[1] Sildenafil[1] Sildenafil 💬[1] PDE5A 💬[3] Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬[1] 86 💬
464Revatio ® 20 mg film-coated tablets[1] Sildenafil[1] Sildenafil 💬[1] PDE5A 💬[3] Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬[1] 86 💬
465Revatio®[1] Sildenafil[1] Sildenafil 💬[1] PDE5A 💬[3] Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬[1] 86 💬
466Riciguat Group----[1] 86 💬
467Rifampin[1] Rifampicin[1] Rifampin 💬--[5] 6, 13, 84, 86, 299 💬
468RIOCIGUAT[1] Riociguat[1] Riociguat 💬[3] GUCY1A1,
GUCY1A2,
GUCY1B1 💬		[11] Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬[6] 51, 84, 86, 88, 225, 299 💬
469Riociguat (Adempas, BAY63-2521)[1] Riociguat[1] Riociguat 💬[3] GUCY1A1,
GUCY1A2,
GUCY1B1 💬		[11] Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬[4] 51, 86, 88, 299 💬
470Riociguat (BAY63-2521)[1] Riociguat[1] Riociguat 💬[3] GUCY1A1,
GUCY1A2,
GUCY1B1 💬		[11] Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬[1] 86 💬
471Riociguat granules 0.3% for oral application[1] Riociguat[1] Riociguat 💬[3] GUCY1A1,
GUCY1A2,
GUCY1B1 💬		[11] Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬[1] 86 💬
472Riociguat Oral Product[1] Riociguat[1] Riociguat 💬[3] GUCY1A1,
GUCY1A2,
GUCY1B1 💬		[11] Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬[1] 86 💬
473Riociguat Oral Tablet[1] Riociguat[1] Riociguat 💬[3] GUCY1A1,
GUCY1A2,
GUCY1B1 💬		[11] Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬[3] 51, 86, 88 💬
474Riociguat Pill[1] Riociguat[1] Riociguat 💬[3] GUCY1A1,
GUCY1A2,
GUCY1B1 💬		[11] Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬[1] 86 💬
475Ritonavir[1] Ritonavir[1] Ritonavir 💬--[3] 2, 86, 265 💬
476RITUXIMAB[1] Rituximab[1] Rituximab 💬[1] MS4A1 💬[1] Hematopoietic cell lineage 💬[48] 11, 13, 14, 19, 26, 35, 36, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 53, 55, 56, 60, 61, 63, 64, 65, 66, 83, 84, 85, 86, 93, 94, 96, 97, 162, 222, 229, 256, 271, 274, 283, 284, 285, 288, 296, 300, 331 💬
477Ro 47-0203----[4] 51, 85, 86, 88 💬
478Ro 47-0203 / ACT-050088----[1] 86 💬
479Ro-47-0203----[1] 86 💬
480Ro-47-0203/029----[1] 86 💬
481Ro47-0203----[1] 86 💬
482Ro47-0203 / ACT-050088----[2] 51, 86 💬
483RoActemra[1] Tocilizumab[1] Tocilizumab 💬[1] IL6R 💬[12] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬[11] 40, 41, 44, 46, 50, 51, 86, 107, 266, 271, 331 💬
484Rodatristat ethyl----[1] 86 💬
485Rodatristat ethyl 300 mg tablet BID----[1] 86 💬
486Rodatristat ethyl 600 mg BID----[1] 86 💬
487RT234 - vardenafil inhalation powder[1] Vardenafil[1] Vardenafil 💬[1] PDE5A 💬[3] Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬[1] 86 💬
488RTA 402----[3] 67, 86, 218 💬
489RVG 33865----[1] 86 💬
490RVT-1201----[1] 86 💬
491Salbutamol[1] Salbutamol[1] Albuterol 💬[1] ADRB2 💬[9] Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[8] 3, 11, 49, 85, 86, 111, 256, 299 💬
492Saline[1] Sodium chloride[1] Sodium chloride 💬--[10] 6, 13, 17, 53, 67, 78, 86, 97, 168, 299 💬
493Sapropterin[1] Sapropterin[1] Sapropterin 💬--[3] 86, 124, 240 💬
494Sapropterin dihydrochloride (6R-BH4)[1] Sapropterin[1] Sapropterin 💬--[1] 86 💬
495Saquinavir[1] Saquinavir[1] Saquinavir 💬--[2] 86, 265 💬
496Saquinavir and ritonavir[2] Ritonavir,
Saquinavir		[2] Ritonavir ,
Saquinavir 💬		--[1] 86 💬
497SATRALIZUMAB[1] Satralizumab[1] Satralizumab 💬[1] IL6R 💬[12] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬[3] 11, 13, 86 💬
498Satralizumab (Genetical Recombination)[1] Satralizumab[1] Satralizumab 💬[1] IL6R 💬[12] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬[1] 86 💬
499Sauerstoff----[2] 86, 88 💬
500SELEXIPAG[1] Selexipag[1] Selexipag 💬[1] PTGIR 💬[3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬[5] 51, 70, 84, 86, 88 💬
501Selexipag (Uptravi)[1] Selexipag[1] Selexipag 💬[1] PTGIR 💬[3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬[1] 86 💬
502Selexipag, ACT-293987 (NS-304)[1] Selexipag[1] Selexipag 💬[1] PTGIR 💬[3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬[1] 86 💬
503Selonsertib[1] Selonsertib[1] Selonsertib 💬[1] MAP3K5 💬[20] Alcoholic liver disease, Alzheimer disease, Amyotrophic lateral sclerosis, Apoptosis, Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Huntington disease, Lipid and atherosclerosis, MAPK signaling pathway, Neurotrophin signaling pathway, Non-alcoholic fatty liver disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Platinum drug resistance, Protein processing in endoplasmic reticulum, Sphingolipid signaling pathway, Spinocerebellar ataxia, TNF signaling pathway, Thermogenesis, Tight junction 💬[1] 86 💬
504Seralutinib----[1] 86 💬
505Serine[1] Serine[1] Serine 💬--[4] 2, 6, 86, 96 💬
506Sham O2 (medical air)[2] Medical air,
Oxygen		[1] Oxygen 💬--[1] 86 💬
507SILDENAF----[1] 86 💬
508Sildenafil[1] Sildenafil[1] Sildenafil 💬[1] PDE5A 💬[3] Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬[17] 6, 46, 50, 51, 85, 86, 90, 113, 210, 211, 212, 225, 226, 278, 294, 299, 301 💬
509Sildenafil (as citrate)[1] Sildenafil[1] Sildenafil 💬[1] PDE5A 💬[3] Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬[1] 86 💬
510Sildenafil (REVATIO)[1] Sildenafil[1] Sildenafil 💬[1] PDE5A 💬[3] Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬[1] 86 💬
511Sildenafil (Revatio) 20 mg TID[1] Sildenafil[1] Sildenafil 💬[1] PDE5A 💬[3] Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬[1] 86 💬
512Sildenafil 20mg[1] Sildenafil[1] Sildenafil 💬[1] PDE5A 💬[3] Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬[2] 51, 86 💬
513Sildenafil 20mg and Bosentan 62.5mg[2] Bosentan,
Sildenafil		[3] Bosentan ,
Bosentan ,
Sildenafil 💬		[3] EDNRA,
EDNRB,
PDE5A 💬		[11] Calcium signaling pathway, Melanogenesis, Metabolic pathways, Neuroactive ligand-receptor interaction, Pathways in cancer, Purine metabolism, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[2] 51, 86 💬
514Sildenafil citrate[1] Sildenafil[1] Sildenafil 💬[1] PDE5A 💬[3] Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬[4] 51, 85, 86, 225 💬
515Sildenafil citrate (UK-92,480)[1] Sildenafil[1] Sildenafil 💬[1] PDE5A 💬[3] Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬[1] 86 💬
516Sildenafil Filmtabletten[1] Sildenafil[1] Sildenafil 💬[1] PDE5A 💬[3] Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬[1] 86 💬
517Sildenafil singly or in association with Bosentan[2] Bosentan,
Sildenafil		[3] Bosentan ,
Bosentan ,
Sildenafil 💬		[3] EDNRA,
EDNRB,
PDE5A 💬		[11] Calcium signaling pathway, Melanogenesis, Metabolic pathways, Neuroactive ligand-receptor interaction, Pathways in cancer, Purine metabolism, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 86 💬
518SILDENAFILO[1] Sildenafil[1] Sildenafil 💬[1] PDE5A 💬[3] Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬[1] 86 💬
519Simvastatin[1] Simvastatin[1] Simvastatin 💬[1] HMGCR 💬[4] AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬[21] 6, 13, 15, 34, 46, 49, 51, 66, 79, 86, 89, 94, 158, 160, 162, 195, 265, 288, 298, 299, 310 💬
520Simvastatin 40 mg[1] Simvastatin[1] Simvastatin 💬[1] HMGCR 💬[4] AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬[1] 86 💬
521Simvastatin 40 mg tablets[1] Simvastatin[1] Simvastatin 💬[1] HMGCR 💬[4] AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬[1] 86 💬
522Sirolimus[1] Sirolimus[1] Sirolimus 💬[1] MTOR 💬[51] AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬[35] 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 98, 137, 157, 158, 192, 222, 277, 278, 279, 280, 281, 283, 300, 331 💬
523Sitaxentan[1] Sitaxentan[1] Sitaxentan 💬[1] EDNRA 💬[7] Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 86 💬
524Sitaxentan sodium[1] Sitaxentan[1] Sitaxentan 💬[1] EDNRA 💬[7] Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 86 💬
525Sitaxsentan[1] Sitaxentan[1] Sitaxentan 💬[1] EDNRA 💬[7] Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 86 💬
526Sitaxsentan alone[1] Sitaxentan[1] Sitaxentan 💬[1] EDNRA 💬[7] Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 86 💬
527Sitaxsentan and Sildenafil[2] Sildenafil,
Sitaxentan		[2] Sitaxentan ,
Sildenafil 💬		[2] EDNRA,
PDE5A 💬		[9] Calcium signaling pathway, Metabolic pathways, Neuroactive ligand-receptor interaction, Pathways in cancer, Purine metabolism, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 86 💬
528SITAXSENTAN SODIUM[1] Sitaxentan[1] Sitaxentan 💬[1] EDNRA 💬[7] Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 86 💬
529Slow Dose Titration Group of Subcutaneous Treprostinil[1] Treprostinil[1] Treprostinil 💬[1] PTGIR 💬[3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬[1] 86 💬
530SODIUM NITRITE[1] Nitrite---[1] 86 💬
531Sodium Nitrite Inhalation Solution[1] Nitrite---[1] 86 💬
532Sodium tanshinone IIA sulfonate diluted with 5% glucose solution,20mg sildenafil citrate by mouth[2] Dextrose, unspecified form,
Sildenafil		[1] Sildenafil 💬[1] PDE5A 💬[3] Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬[1] 86 💬
533Sorafenib[1] Sorafenib[1] Sorafenib 💬[8] BRAF,
FLT3,
FLT4,
KDR,
KIT,
PDGFRB,
RAF1,
RET 💬		[89] Acute myeloid leukemia, Alcoholism, Alzheimer disease, Apelin signaling pathway, Apoptosis, Autophagy - animal, Axon guidance, B cell receptor signaling pathway, Bladder cancer, Breast cancer, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Choline metabolism in cancer, Chronic myeloid leukemia, Colorectal cancer, Cushing syndrome, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endometrial cancer, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Fluid shear stress and atherosclerosis, Focal adhesion, FoxO signaling pathway, Gap junction, Gastric cancer, Glioma, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Hepatocellular carcinoma, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Influenza A, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Long-term depression, Long-term potentiation, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-small cell lung cancer, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Renal cell carcinoma, Salmonella infection, Serotonergic synapse, Signaling pathways regulating pluripotency of stem cells, Sphingolipid signaling pathway, T cell receptor signaling pathway, Thyroid cancer, Thyroid hormone signaling pathway, Transcriptional misregulation in cancer, Tuberculosis, VEGF signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway, mTOR signaling pathway 💬[2] 34, 86 💬
534SOTATERCEPT[1] Sotatercept[1] Sotatercept 💬[1] ACVR2A 💬[4] Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Signaling pathways regulating pluripotency of stem cells, TGF-beta signaling pathway 💬[2] 86, 284 💬
535Sotatercept - 45 mg/vial[1] Sotatercept[1] Sotatercept 💬[1] ACVR2A 💬[4] Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Signaling pathways regulating pluripotency of stem cells, TGF-beta signaling pathway 💬[1] 86 💬
536Sotatercept - 60 mg/vial[1] Sotatercept[1] Sotatercept 💬[1] ACVR2A 💬[4] Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Signaling pathways regulating pluripotency of stem cells, TGF-beta signaling pathway 💬[1] 86 💬
537Spironolactone[1] Spironolactone[1] Spironolactone 💬[1] NR3C2 💬[1] Aldosterone-regulated sodium reabsorption 💬[8] 46, 58, 67, 86, 113, 210, 218, 225 💬
538Spironolactone and conivaptan[2] Conivaptan,
Spironolactone		[2] Spironolactone ,
Conivaptan 💬		[3] AVPR1A,
AVPR2,
NR3C2 💬		[6] Aldosterone-regulated sodium reabsorption, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vascular smooth muscle contraction, Vasopressin-regulated water reabsorption 💬[1] 86 💬
539Spironolactone captopril carvedilol[3] Captopril,
Carvedilol,
Spironolactone		[3] Captopril ,
Carvedilol ,
Spironolactone 💬		[7] ACE,
ADRA1A,
ADRA1B,
ADRA1D,
ADRB1,
ADRB2,
NR3C2 💬		[19] AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Aldosterone-regulated sodium reabsorption, Calcium signaling pathway, Chagas disease, Chemical carcinogenesis - receptor activation, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Dilated cardiomyopathy, Gap junction, Hypertrophic cardiomyopathy, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Renin-angiotensin system, Salivary secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 86 💬
540STI571----[2] 51, 86 💬
541Subcutaneous and intravenous prostacyclin[1] Epoprostenol[1] Epoprostenol 💬[1] PTGIR 💬[3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬[1] 86 💬
542Subcutaneous Treprostinil[1] Treprostinil[1] Treprostinil 💬[1] PTGIR 💬[3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬[1] 86 💬
543Sugar pill----[8] 5, 6, 49, 67, 70, 86, 206, 210 💬
544SULFASALAZINE[1] Sulfasalazine[1] Sulfasalazine 💬--[6] 46, 86, 94, 107, 270, 271 💬
545Sulfate[1] Sulfate ion---[27] 2, 3, 6, 11, 13, 26, 28, 34, 36, 46, 49, 53, 60, 64, 66, 85, 86, 96, 111, 218, 222, 224, 226, 265, 296, 297, 299 💬
546Tadalafil[1] Tadalafil[1] Tadalafil 💬[1] PDE5A 💬[3] Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬[7] 6, 51, 75, 84, 86, 113, 210 💬
547Tadalafil 20 mg film-coated tablets[1] Tadalafil[1] Tadalafil 💬[1] PDE5A 💬[3] Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬[1] 86 💬
548Tadalafil 40 mg[1] Tadalafil[1] Tadalafil 💬[1] PDE5A 💬[3] Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬[1] 86 💬
549Tadalafil and ambrisentan upfront combination therapy[2] Ambrisentan,
Tadalafil		[2] Tadalafil ,
Ambrisentan 💬		[2] EDNRA,
PDE5A 💬		[9] Calcium signaling pathway, Metabolic pathways, Neuroactive ligand-receptor interaction, Pathways in cancer, Purine metabolism, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[2] 51, 86 💬
550Tadalafil oral suspension[1] Tadalafil[1] Tadalafil 💬[1] PDE5A 💬[3] Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬[1] 86 💬
551Tadalafil- Tablet or Oral suspension[1] Tadalafil[1] Tadalafil 💬[1] PDE5A 💬[3] Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬[1] 86 💬
552TADALAFILO[1] Tadalafil[1] Tadalafil 💬[1] PDE5A 💬[3] Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬[1] 86 💬
553Tasigna[1] Nilotinib[1] Nilotinib 💬[4] ABL1,
KIT,
PDGFRA,
PDGFRB 💬		[33] Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 💬[2] 34, 86 💬
554Tasigna®[1] Nilotinib[1] Nilotinib 💬[4] ABL1,
KIT,
PDGFRA,
PDGFRB 💬		[33] Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 💬[1] 86 💬
555Tasigna® 150 mg[1] Nilotinib[1] Nilotinib 💬[4] ABL1,
KIT,
PDGFRA,
PDGFRB 💬		[33] Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 💬[1] 86 💬
556TBD----[5] 19, 86, 90, 276, 299 💬
557Tegaderm----[1] 86 💬
558Terguride[1] Terguride[1] Terguride 💬[2] DRD2,
PRL 💬		[12] Alcoholism, Cocaine addiction, Cytokine-cytokine receptor interaction, Dopaminergic synapse, Gap junction, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Parkinson disease, Prolactin signaling pathway, Rap1 signaling pathway, cAMP signaling pathway 💬[2] 51, 86 💬
559Terguride 0,5mg tablet[1] Terguride[1] Terguride 💬[2] DRD2,
PRL 💬		[12] Alcoholism, Cocaine addiction, Cytokine-cytokine receptor interaction, Dopaminergic synapse, Gap junction, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Parkinson disease, Prolactin signaling pathway, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 86 💬
560Terguride 0.5 mg tablet[1] Terguride[1] Terguride 💬[2] DRD2,
PRL 💬		[12] Alcoholism, Cocaine addiction, Cytokine-cytokine receptor interaction, Dopaminergic synapse, Gap junction, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Parkinson disease, Prolactin signaling pathway, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 86 💬
561Tezosentan[1] Tezosentan---[1] 86 💬
562The POP02 study is collecting bodily fluid samples (i.e., whole blood, effluent samples) of children prescribed the following drugs of interest per standard of care:----[1] 86 💬
563The POPS study is collecting PK data on children prescribed the following drugs of interest per standard of care:----[1] 86 💬
564Thelin[1] Sitaxentan[1] Sitaxentan 💬[1] EDNRA 💬[7] Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 86 💬
565Threonine[1] Threonine[1] Threonine 💬--[2] 86, 97 💬
566Tocilizumab[1] Tocilizumab[1] Tocilizumab 💬[1] IL6R 💬[12] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬[21] 2, 11, 13, 40, 41, 42, 43, 44, 46, 49, 50, 51, 53, 54, 55, 56, 86, 107, 266, 271, 331 💬
567TOLVAPTAN[1] Tolvaptan[1] Tolvaptan 💬[1] AVPR2 💬[3] Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬[4] 67, 72, 86, 225 💬
568TPN171H----[1] 86 💬
569TPN171H single dose----[1] 86 💬
570Traclear----[1] 86 💬
571Tracleer[1] Bosentan[2] Bosentan ,
Bosentan 💬		[2] EDNRA,
EDNRB 💬		[9] Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[8] 13, 51, 84, 85, 86, 88, 210, 211 💬
572TRACLEER 62,5 mg comprimidos recubiertos con película[1] Bosentan[2] Bosentan ,
Bosentan 💬		[2] EDNRA,
EDNRB 💬		[9] Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 86 💬
573TRACLEER 62,5MG 56CPR RIV.[1] Bosentan[2] Bosentan ,
Bosentan 💬		[2] EDNRA,
EDNRB 💬		[9] Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 86 💬
574TRACLEER*125MG 56CPR RIV.[1] Bosentan[2] Bosentan ,
Bosentan 💬		[2] EDNRA,
EDNRB 💬		[9] Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[2] 51, 86 💬
575TRACLEER*56CPR RIV 125MG[1] Bosentan[2] Bosentan ,
Bosentan 💬		[2] EDNRA,
EDNRB 💬		[9] Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[3] 51, 86, 88 💬
576Tracleer®----[1] 86 💬
577Transdihydrolisuride----[2] 51, 86 💬
578TRE----[1] 86 💬
579Treprosinil Diethanolamine----[1] 86 💬
580Treprostin----[1] 86 💬
581Treprostinil[1] Treprostinil[1] Treprostinil 💬[1] PTGIR 💬[3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬[6] 51, 84, 85, 86, 88, 210 💬
582Treprostinil dietanolamina[1] Treprostinil[1] Treprostinil 💬[1] PTGIR 💬[3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬[1] 86 💬
583Treprostinil diethanolamine[1] Treprostinil[1] Treprostinil 💬[1] PTGIR 💬[3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬[2] 51, 86 💬
584Treprostinil Diolamine[1] Treprostinil[1] Treprostinil 💬[1] PTGIR 💬[3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬[1] 86 💬
585Treprostinil Inhalation Powder[1] Treprostinil[1] Treprostinil 💬[1] PTGIR 💬[3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬[1] 86 💬
586Treprostinil inhalations[1] Treprostinil[1] Treprostinil 💬[1] PTGIR 💬[3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬[1] 86 💬
587Treprostinil Injectable Product[1] Treprostinil[1] Treprostinil 💬[1] PTGIR 💬[3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬[1] 86 💬
588Treprostinil Palmitil[1] Treprostinil[1] Treprostinil 💬[1] PTGIR 💬[3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬[1] 86 💬
589TREPROSTINIL SODIUM[1] Treprostinil[1] Treprostinil 💬[1] PTGIR 💬[3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬[3] 51, 86, 88 💬
590Treprostinil Sodium Solution for Inhalation[1] Treprostinil[1] Treprostinil 💬[1] PTGIR 💬[3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬[1] 86 💬
591TREPROSTINIL SODIUM, UT-15[1] Treprostinil[1] Treprostinil 💬[1] PTGIR 💬[3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬[1] 86 💬
592Treprostinil, UT-15, LRX-15, 15AU81, BW A15AU, U-62, 840[1] Treprostinil[1] Treprostinil 💬[1] PTGIR 💬[3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬[1] 86 💬
593Treprostinilo[1] Treprostinil[1] Treprostinil 💬[1] PTGIR 💬[3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬[1] 86 💬
594Trimetazidine[1] Trimetazidine[1] Trimetazidine 💬--[3] 2, 58, 86 💬
595Trisuva(r)----[1] 86 💬
596TRK-100STP----[1] 86 💬
597Tyrosine[1] Tyrosine[1] Tyrosine 💬--[3] 6, 86, 111 💬
598Tyvaso[1] Treprostinil[1] Treprostinil 💬[1] PTGIR 💬[3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬[1] 86 💬
599Tyvaso Inhalation Solution[1] Treprostinil[1] Treprostinil 💬[1] PTGIR 💬[3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬[1] 86 💬
600Ubenimex[1] Ubenimex[1] Ubenimex 💬[1] ANPEP 💬[4] Glutathione metabolism, Hematopoietic cell lineage, Metabolic pathways, Renin-angiotensin system 💬[1] 86 💬
601Udenafil[1] Udenafil[1] Udenafil 💬[1] PDE5A 💬[3] Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬[2] 86, 210 💬
602UK 092480----[1] 86 💬
603UK-92,480----[1] 86 💬
604UK-92,480-10----[1] 86 💬
605ULARITIDE[1] Ularitide---[1] 86 💬
606Uptravi[1] Selexipag[1] Selexipag 💬[1] PTGIR 💬[3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬[3] 84, 86, 88 💬
607Urodilatin----[1] 86 💬
608UT-15C----[1] 86 💬
609UT-15C (treprostinil diethanolamine)[1] Treprostinil[1] Treprostinil 💬[1] PTGIR 💬[3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬[1] 86 💬
610UT-15C 0.25 mg----[1] 86 💬
611UT-15C 1 mg----[1] 86 💬
612UT-15C 5 mg----[1] 86 💬
613UT-15C LP----[1] 86 💬
614UT-15C SR----[2] 51, 86 💬
615UT-15C SR (treprostinil diethanolamine)[1] Treprostinil[1] Treprostinil 💬[1] PTGIR 💬[3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬[1] 86 💬
616UT-15C-SR----[2] 51, 86 💬
617Vardenafil[1] Vardenafil[1] Vardenafil 💬[1] PDE5A 💬[3] Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬[3] 13, 86, 299 💬
618Vasomera (PB1046) Injection----[1] 86 💬
619Veletri[1] Epoprostenol[1] Epoprostenol 💬[1] PTGIR 💬[3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬[1] 86 💬
620Ventavis[1] Iloprost[1] Iloprost 💬[1] PTGIR 💬[3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬[1] 86 💬
621Ventavis (Iloprost, BAYQ6256)[1] Iloprost[1] Iloprost 💬[1] PTGIR 💬[3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬[1] 86 💬
622Ventavis 10[1] Iloprost[1] Iloprost 💬[1] PTGIR 💬[3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬[1] 86 💬
623Ventavis(Iloprost)[1] Iloprost[1] Iloprost 💬[1] PTGIR 💬[3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬[1] 86 💬
624VIAGRA[1] Sildenafil[1] Sildenafil 💬[1] PDE5A 💬[3] Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬[3] 86, 96, 225 💬
625VIP----[3] 49, 51, 86 💬
626Volibris[1] Ambrisentan[1] Ambrisentan 💬[1] EDNRA 💬[7] Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[4] 51, 85, 86, 88 💬
627VOLIBRIS 10 mg comprimidos recubiertos con película[1] Ambrisentan[1] Ambrisentan 💬[1] EDNRA 💬[7] Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 86 💬
628VOLIBRIS 5 mg comprimidos recubiertos con película[1] Ambrisentan[1] Ambrisentan 💬[1] EDNRA 💬[7] Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 86 💬
629VOLIBRIS® (ambrisentan)[1] Ambrisentan[1] Ambrisentan 💬[1] EDNRA 💬[7] Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 86 💬
630VOLIBRIS™ tablets[1] Ambrisentan[1] Ambrisentan 💬[1] EDNRA 💬[7] Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 86 💬
631Warfarin[1] Warfarin[1] Warfarin 💬[2] NQO1,
VKORC1 💬		[7] Biosynthesis of cofactors, Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Metabolic pathways, Pathways in cancer, Ubiquinone and other terpenoid-quinone biosynthesis 💬[11] 6, 8, 13, 19, 46, 49, 66, 85, 86, 88, 91 💬
632ZAMICASTAT[1] Zamicastat---[1] 86 💬